GlassScriptPhysician profile
Natraj Katta
NPI 1417125303
$17,703.63
in general payments reported to CMS, 2019-2025
26 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,374 · 2020: $3,273 · 2021: $506 · 2022: $9,539 · 2023: $774 · 2024: $1,009 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,011.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,676.47 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Abbott Laboratories | $4,429.72 | 2019-2025 | Optis, Xience Skypoint, Dragonfly Opstar |
| Medtronic Vascular, INC. | $2,187.23 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,350.19 | 2019-2020 | |
| Inari Medical, INC. | $1,317.53 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $458.45 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $409.71 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $351.70 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $326.12 | 2019-2022 | |
| Chiesi USA, INC. | $311.22 | 2019-2023 | Kengreal, Cleviprex |
| Boston Scientific Corporation | $298.08 | 2019-2024 | |
| Abiomed | $241.10 | 2019-2023 | Impella |
| Janssen Pharmaceuticals, INC | $213.53 | 2019-2022 | |
| Philips North America LLC | $188.93 | 2019-2022 | |
| Amgen INC. | $181.71 | 2022-2024 | Repatha |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $172.66 | 2019 | |
| Biosense Webster, INC. | $127.51 | 2023 | Nuvision Ice Catheter |
| Pfizer INC. | $118.23 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $78.09 | 2019-2021 | |
| Stryker Corporation | $73.01 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Saranas, INC. | $66.71 | 2022 | |
| Heartflow, INC. | $41.58 | 2024 | |
| Sanofi-Aventis U.S. LLC | $35.52 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.43 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.20 | 2024 | Farxiga |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natraj Katta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.